High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli

被引:142
作者
Iwata, H
Fujita, K
Kushida, H
Suzuki, A
Konno, Y
Nakamura, K
Fujino, A
Kamataki, T
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Div Drug Metab, Kita Ku, Sapporo, Hokkaido 060, Japan
[2] Mitsubishi Chem Safety Inst Ltd, Dept Drug Metab, Hasaki, Ibaraki 31402, Japan
关键词
human P450; heterologous expression; E-coli; drug metabolism;
D O I
10.1016/S0006-2952(97)00643-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Forms of human cytochrome P450 (P450 or CYP), such as CYP1A1, CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4, were expressed or co-expressed together with human NADPH P450 reductase in Escherichia coli. When P450 was expressed alone in E. coli, the expression level of holo-P450 ranged from 310 to 1620 nmol/L of culture. The expression level of holo-P450 decreased by co-expression with the reductase, and the level ranged from 66 to 381 nmol/L of culture. The expression level of the reductase varied depending on the forms of P450 co-expressed, and ranged from 204 to 937 U/L of culture. We assayed the catalytic activity of P450 using E. coli cells disrupted by freeze-thaw. When co expressed with the reductase, human P450 catalyzed the oxidation of representative substrates at efficient rates. The rates appeared comparable to the reported activities of P450 in a reconstituted system containing purified preparations of P450 and the reductase. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:1315 / 1325
页数:11
相关论文
共 73 条
  • [11] HEPATIC-MICROSOMAL TOLBUTAMIDE HYDROXYLATION IN JAPANESE - INVITRO EVIDENCE FOR RAPID AND SLOW METABOLIZERS
    CHEN, LS
    YASUMORI, T
    YAMAZOE, Y
    KATO, R
    [J]. PHARMACOGENETICS, 1993, 3 (02): : 77 - 85
  • [12] CRESPI CL, 1991, DRUG METAB DISPOS, V22, P688
  • [13] CRESTEIL T, 1994, CANCER RES, V54, P386
  • [14] STEREOSELECTIVITY AND REGIOSELECTIVITY OF HEPATIC OXIDATION IN MAN - EFFECT OF THE DEBRISOQUINE SPARTEINE PHENOTYPE ON BUFURALOL HYDROXYLATION
    DAYER, P
    LEEMANN, T
    KUPFER, A
    KRONBACH, T
    MEYER, UA
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (03) : 313 - 318
  • [15] STABLE EXPRESSION OF RAT CYTOCHROME P-450IIB1 CDNA IN CHINESE-HAMSTER CELLS (V79) AND METABOLIC-ACTIVATION OF AFLATOXIN-B1
    DOEHMER, J
    DOGRA, S
    FRIEDBERG, T
    MONIER, S
    ADESNIK, M
    GLATT, H
    OESCH, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) : 5769 - 5773
  • [16] Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli
    Dong, JS
    Porter, TD
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 327 (02) : 254 - 259
  • [17] HIGH-LEVEL EXPRESSION OF FUNCTIONAL HUMAN CYTOCHROME-P450 1A2 IN ESCHERICHIA-COLI
    FISHER, CW
    CAUDLE, DL
    MARTINWIXTROM, C
    QUATTROCHI, LC
    TUKEY, RH
    WATERMAN, MR
    ESTABROOK, RW
    [J]. FASEB JOURNAL, 1992, 6 (02) : 759 - 764
  • [18] EXPRESSION OF CYTOCHROME-P450-3A5 IN ESCHERICHIA-COLI - EFFECTS OF 5' MODIFICATION, PURIFICATION, SPECTRAL CHARACTERIZATION, RECONSTITUTION CONDITIONS, AND CATALYTIC ACTIVITIES
    GILLAM, EMJ
    GUO, ZY
    UENG, YF
    YAMAZAKI, H
    COCK, I
    REILLY, PEB
    HOOPER, WD
    GUENGERICH, FP
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 317 (02) : 374 - 384
  • [19] EXPRESSION OF CYTOCHROME-P450 2D6 IN ESCHERICHIA-COLI, PURIFICATION, AND SPECTRAL AND CATALYTIC CHARACTERIZATION
    GILLAM, EMJ
    GUO, ZY
    MARTIN, MV
    JENKINS, CM
    GUENGERICH, FP
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (02) : 540 - 550
  • [20] EXPRESSION OF MODIFIED HUMAN CYTOCHROME-P450 2E1 IN ESCHERICHIA-COLI, PURIFICATION, AND SPECTRAL AND CATALYTIC PROPERTIES
    GILLAM, EMJ
    GUO, ZY
    GUENGERICH, FP
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 312 (01) : 59 - 66